BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Vascular Endothelial Growth Factor Receptor-2

Below is an extended Vascular Endothelial Growth Factor Receptor-2 research listing. Click here to return to the Vascular Endothelial Growth Factor Receptor-2 main in depth entry.

Recent Publications on Vascular Endothelial Growth Factor Receptor-2:

Modulation of 11beta-Hydroxysteroid Dehydrogenase Expression by Bombesin: A Possible Mechanism for Glucocorticoid Resistance in Androgen Independent Prostate Cancer.
Treatment with glucocorticoids is one of a limited number of options for...
Direct Link
30th August, 2008
1Department of Urology, Urological Oncology laboratory, Weill Medical
[Transient gene expression of soluble VEGFR2: I-IV] 30th August, 2008
State Key Laboratory of Bioreactor Engineering, East China University of
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Angiogenesis occurs during normal physiologic processes as well as under...
Direct Link
30th August, 2008
Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701-9322.
Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells.
In this study characterization of endothelial cells differentiated from...
Direct Link
30th August, 2008
Department of Clinical Biochemistry, Tarbiat Modares University, Tehran,
Endothelial progenitor cells in vascular repair and remodeling.
Postnatal bone marrow contains a subtype of unique progenitor cells that...
Direct Link
30th August, 2008
Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen
Tumor angiogenesis.
Postnatal bone marrow contains a subtype of unique progenitor cells that...
Direct Link
30th August, 2008
[Influence of neoadjuvant therapy on VEGFR-2 levels in tumor and blood serum from breast cancer patients] 30th August, 2008
Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development.
OBJECTIVE: We examined the pulmonary expression of 2 proangiogenic...
Direct Link
23rd August, 2008
Hospital for Children and Adolescents, Helsinki, Finland.
Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors.
We have discovered novel inhibitors of VEGFR-2 kinase with low nanomolar...
Direct Link
23rd August, 2008
Department of Chemistry, ImClone Systems Incorporated, New York, NY 10014,
Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.
The simultaneous targeting of both endothelial cells and pericytes via...
Direct Link
20th August, 2008
Division of Hematology, Stanford University School of Medicine, Stanford,
Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
PURPOSE: Adenoid cystic carcinoma (ACC) can often be controlled with...
Direct Link
14th August, 2008
Department of Head and Neck Surgery, The University of Texas M. D.
Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: Involvement of the vascular endothelial growth factor receptor 2.
In recent years, evidence has accumulated that many endogenous peptides...
Direct Link
12th August, 2008
Department of Human Anatomy and Physiology (Anatomy Section), University
The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues.
Here we identify the pharmacophore in a peptoid that antagonizes Vascular...
Direct Link
26th July, 2008
Department of Internal Medicine and Molecular Biology, Division of
Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
Parathyroid hormone-related protein (PTHrP) (107-139), in contrast to the...
Direct Link
25th July, 2008
Laboratorio de Metabolismo Mineral y Oseo, Fundacion Jimenez Diaz (Capio
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.
Thymoquinone, a component derived from the medial plant Nigella sativa,...
Direct Link
23rd July, 2008
Center for Cancer and Stem Cell Biology, Institute for Bioscience and
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional